Longer time from diagnosis to docetaxel treatment results in a shorter survival in metastatic hormonosensitive prostate cancer (mHSPC) patients treated with chemotherapy plus androgen deprivation therapy (ADT)

被引：0
|
作者：
Duran, M. A. Climent [1 ]
Mellado, B. [2 ]
Rodriguez, J. M. Piulats [3 ]
Lopez, L. Heras [4 ]
Juan, M. J. [1 ]
Saez, M. I. [5 ]
Reig, O. [2 ]
Montesa, A. [6 ]
Suarez, J. F. [7 ]
Hajianfar, R. [8 ]
Ribal, M. J. [2 ]
Rubio, J. [1 ]
Castells, M. [7 ]
Villatoro, R. [9 ]
Sandiego, S. [1 ]
Hidalgo, D. Olmos [10 ]
机构：
[1] Fdn Inst Valenciano Oncol, Med Oncol, Valencia, Spain
[2] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
[3] Inst Catala Oncol, Med Oncol, Barcelona, Spain
[4] Hosp St Joan Despi Moises Broggi, Med Oncol, St Joan Despi, Spain
[5] H Univ Virgen Victoria & Reg Malaga, Med Oncol, Malaga, Spain
[6] Hosp Univ Virgen Victoria & Reg Malaga, CNIO IBIMA Genitourinary Res Unit, Malaga, Spain
[7] Hosp Bellvitge Princeps Espanya, Urol, Barcelona, Spain
[8] Hosp St Joan Despi Moises Broggi, Urol, St Joan Despi, Spain
[9] Hosp Costa Sol, Med Oncol, Malaga, Spain
[10] Spanish Natl Canc Res Ctr, Prostate Canc Clin Res Unit, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
814P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    Ito, Tetsuro
    Grant, Laura
    Duckham, Bryony R.
    Ribbands, Amanda J.
    Gater, Adam
    ADVANCES IN THERAPY, 2018, 35 (12) : 2186 - 2200
  • [2] Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    Tetsuro Ito
    Laura Grant
    Bryony R. Duckham
    Amanda J. Ribbands
    Adam Gater
    Advances in Therapy, 2018, 35 : 2186 - 2200
  • [3] Androgen deprivation therapy (ADT) plus docetaxel versus ADT alone in chinese men with high volume metastatic prostate cancer
    Cheng, N. M. Y.
    Teoh, J. Y. C.
    Poon, D. M.
    Hou, S. M.
    Ng, C. F.
    BJU INTERNATIONAL, 2017, 119 : 6 - 6
  • [4] Age-dependent administration and survival benefit of androgen deprivation therapy (ADT) vs. chemotherapy plus ADT (C plus ADT) in metastatic prostate cancer (mPC).
    Keating, Matthew
    Mukkamalla, Shiva Kumar Reddy
    Giscombe, Lisa
    Reddy, Nishitha
    Desouza, Andre
    Rathore, Ritesh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Randomized trial of androgen deprivation therapy (ADT) plus enzalutamide (Arm A) versus ADT plus bicalutamide (Arm B) in metastatic hormone sensitive prostate cancer (mHSPC)
    Vaishampayan, U. N.
    Heilbrun, L.
    Monk, P.
    Sonpavde, G.
    Tejwani, S.
    Heath, E. I.
    Fontana, J.
    Chinni, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Comparative efficacy and cost-effectiveness of maximum androgen blockade (MAB), docetaxel with androgen deprivation therapy (ADT), and ADT alone for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) in China
    Jiang, W.
    Qu, S.
    Liu, Y.
    Yao, X.
    Liu, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 276 - 276
  • [7] Tolerability and pharmacokinetic analyses of combination therapy with darolutamide (DARO), androgen-deprivation therapy (ADT), and docetaxel (DOC) in patients with metastatic hormone sensitive prostate cancer (mHSPC) from ARASENS
    Tombal, B.
    Smith, M. R.
    Hussain, M.
    Saad, F.
    Fizazi, K.
    Sternberg, C. N.
    Crawford, E. D.
    Kapur, S.
    Zhang, W.
    Ploeger, B.
    Li, R.
    Kuss, I.
    Zieschang, C.
    Wittemer-Rump, S.
    Rezazadeh, Kalebasty A.
    EUROPEAN UROLOGY, 2023, 83
  • [8] Association of time from definitive therapy (DT) to start of androgen deprivation therapy (ADT) for metastatic disease and survival outcomes in men with new metastatic hormone-sensitive prostate cancer (mHSPC).
    Gill, David Michael
    Stenehjem, David D.
    Cheng, Heather H.
    Kessler, Elizabeth Riley
    Hahn, Andrew W.
    Gupta, Sumati
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [9] Improved survival of men with metastatic prostate cancer treated with androgen deprivation therapy plus radiotherapy to the prostate
    Yano, Akihiro
    Kagawa, Makoto
    Takeshita, Hideki
    Okada, Yohei
    Morozumi, Makoto
    Kawakami, Satoru
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (12) : 863 - 865
  • [10] SEXUAL LIFE OF PROSTATE CANCER PATIENTS TREATED WITH ADT (ANDROGEN DEPRIVATION THERAPY)
    Soebadi, Doddy M.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 302 - 302
12345